Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

Growth Hormone Clinical Trial

Official title:
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

Status Completed

Clinical Trial Summary

This retrospective cohort study aims to investigate the effects of recombinant human growth hormone (rh-GH) on the euploid status of preimplantation blastocysts in AMA patients. Infertile patients aged 38-46 years old were recruited for study if they fulfill the inclusion criteria and do not have the exclusion criteria. Treatment group: Women received growth hormone (GH) supplement during antagonist protocol for ovarian stimulation. Control group: Women received antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts per stimulation cycle and per testing cycle.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Growth Hormone

Clinical Trial Details

NCT number	NCT05574894
Study type	Interventional
Source	ShangHai Ji Ai Genetics & IVF Institute
Contact
Status	Completed
Phase	Phase 3
Start date	January 1, 2021
Completion date	September 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04079010` - The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone	N/A
Completed	`NCT01540773` - Single Low-Dose of Supplement Amino Acid	N/A
Completed	`NCT00562796` - Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity	N/A
Completed	`NCT01158612` - The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella	N/A
Recruiting	`NCT05447208` - Effect of GH on the Blastocyst Euploid Rate in AMA Patients	Phase 3
Completed	`NCT00966134` - Ghrelin, Growth Hormone and Growth Factors at High Altitude	N/A
Active, not recruiting	`NCT06433375` - Evaluation of the Efficacy of Growth Hormone on Healing of Periapical Pathosis	N/A